Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 159
Immune Disorders Drugs 82
Genomics 79
Biopharmaceuticals 78
Drug Discovery 68
Oncology Drugs 55
Biotechnology 53
Pharmaceuticals 46
Musculoskeletal Disorders Drugs 44
Hematological Drugs 40
Clinical Trials 30
Biosimilars and Biosuperiors 30
Cardiovascular Drugs 29
Alzheimer's Disease Drugs 26
Allergy and Immunology 23
Mental Disorders Drugs 21
Infusions and Injectables 20
Optical Disorders Drugs 18
Infectious Diseases Drugs 18
Gastrointestinal Drugs 17
Respiratory Drugs 17
Needles and Syringes 16
Neurology 15
E-Healthcare 15
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Healthcare Services 13
Lymphoma Drugs 12
Hematology 12
Drug Delivery 11
Endocrine and Metabolic Disorders Drugs 11
Analgesics 10
Optical 10
Drugs by Therapeutic Area 9
Leukemia Drugs 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 8
Pulmonary Medicine 8
Oncology 7
Company Reports 6
Enzymes 6
Medical Devices 6
Hospital Management 5
Cardiology 5
Schizophrenia Drugs 5
Pharmacoeconomics 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Lung Cancer Drugs 3
Stem Cells 3
Dermatology 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Skin Cancer Drugs 2
Nanomedicine 2
Pediatrics 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

939 Results (Page 27 of 47)
- Relevance
  Sort by

Retinal Disorder Treatment - Global Strategic Business Report

 Report
July 2025
375 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Digital Biomarkers Market by Component, Biomarker Type, Functionality, Application, End User, Therapeutic Area - Global Forecast to 2030

 Report
May 2025
181 Pages
Global

From

€3115EUR$3,545USD£2,687GBP

€3461EUR$3,939USD£2,986GBP

Acute Spinal Cord Injury Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3945EUR$4,490USD£3,403GBP

Gene Therapy - Global Strategic Business Report

 Report
July 2025
411 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Biobetter Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
112 Pages
Global

From

€3500EUR$4,267USD£3,125GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Central Nervous System (CNS) Stimulant Drugs - Global Strategic Business Report

 Report
July 2025
362 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Frontotemporal Dementia - Global Strategic Business Report

 Report
July 2025
381 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Diabetic Neuropathic Pain - Global Strategic Business Report

 Report
July 2025
384 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Protein 50S Ribosomal Subunit Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1318EUR$1,500USD£1,137GBP

Dilated Cardiomyopathy Therapeutics Market by Therapeutic Class, Treatment Modality, Route Of Administration, End User, Distribution Channel - Global Forecast to 2030

 Report
May 2025
199 Pages
Global

From

€3115EUR$3,545USD£2,687GBP

€3461EUR$3,939USD£2,986GBP

Thrombosis Drugs Market 2024-2028

 Report
August 2024
144 Pages
Global

From

€2197EUR$2,500USD£1,895GBP

Age-Related Macular Degeneration Market Size, Share and Trends Analysis Report by Product (Eylea, Lucentis), Disease (Wet AMD, Dry AMD), Distribution Channel, and Region 2024-2030

 Report
September 2024
100 Pages
Global

From

€5228EUR$5,950USD£4,510GBP

Intramuscular Drug Dilutor Market by Product Type, Diluent Type, End User, Distribution Channel, Application - Global Forecast to 2030

 Report
May 2025
199 Pages
Global

From

€3115EUR$3,545USD£2,687GBP

€3461EUR$3,939USD£2,986GBP

Multiple Sclerosis Therapeutics - Global Strategic Business Report

 Report
July 2025
164 Pages
Global

From

€4789EUR$5,450USD£4,131GBP

Neurodegenerative Drugs - Global Strategic Business Report

 Report
July 2025
376 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Cerebral Infarction Treatment - Global Strategic Business Report

 Report
July 2025
372 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Neuralgia Treatment - Global Strategic Business Report

 Report
July 2025
276 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Dementia Treatment - Global Strategic Business Report

 Report
July 2025
204 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Blarcamesine - Global Strategic Business Report

 Report
July 2025
370 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

Multiple Sclerosis Drugs - Global Strategic Business Report

 Report
July 2025
235 Pages
Global

From

€5140EUR$5,850USD£4,434GBP

939 Results (Page 27 of 47)
- 1
- 25
- 26
- 27
- 28
- 29

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.